Diphe-img-01.jpg (Diphe Img 01)
Diphenhydramine Injection, Solution
Product Images NDC 65219-820
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diphenhydramine (NDC 65219-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Diphe-label-01.jpg (Diphe Label 01)
This is a description of a medication labeled as Diphenhydramine Hydrochloride Injection, USP with a concentration of 50 mg per mL. It is a high potency medication intended for intramuscular or intravenous use. The medication is available in a 1mL single-dose vial and should be protected from light and freezing. The manufacturer is Fresenius Kabi.*
Diphe-label-02.jpg (Diphe Label 02)
This is a description of Diphenhydramine Hydrochloride Injection, USP with 50 mg per mL high potency formulation for intramuscular or intravenous use. Each mL contains Diphenhydramine hydrochloride and water for injection, with pH adjustment as needed. The usual dosage range is 10 to 50 mg. It comes in 25 single dose vials and should be stored at 20° to 25°C, protected from light and freezing. The container closure is latex-free. Reference NDC 65219-820-01 for ordering.*
Diphe-struc-01.jpg (Diphe Struc 01)
Not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
